Uroplakin II Is a More Sensitive Immunohistochemical Marker Than Uroplakin III in Urothelial Carcinoma and Its Variants | Zendy

Wenping Li | Zendy; Yu Liang | Zendy; Michael T. Deavers | Zendy; Ashish M. Kamat | Zendy; Surena F. Matin | Zendy; Colin P. Dinney | Zendy; Bogdan Czerniak | Zendy; Charles C. Guo | Zendy

AI Assistant Blog Pricing

Open Access

Uroplakin II Is a More Sensitive Immunohistochemical Marker Than Uroplakin III in Urothelial Carcinoma and Its Variants

Author(s) -

Wenping Li,

Yu Liang,

Michael T. Deavers,

Ashish M. Kamat,

Surena F. Matin,

Colin P. Dinney,

Bogdan Czerniak,

Charles C. Guo

Publication year - 2014

Publication title -

american journal of clinical pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.859

H-Index - 128

eISSN - 1943-7722

pISSN - 0002-9173

DOI - 10.1309/ajcp1j0jpjbpsuxf

Subject(s) - immunohistochemistry , tissue microarray , pathology , biology , urothelial carcinoma , urinary bladder , carcinoma , bladder cancer , medicine , cancer , genetics

Uroplakin (UP) II and UPIII are highly specific immunohistochemical markers for urothelial differentiation. Here we studied the sensitivity of UPII and UPIII in conventional and variant urothelial carcinomas (UCs).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog